Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: a 1-year prospective study by Chong Guan Ng et al.
RESEARCH Open Access
Anxiety, depression, perceived social
support and quality of life in Malaysian
breast cancer patients: a 1-year prospective
study
Chong Guan Ng1*, Salina Mohamed2, Mee Hoong See3, Faizah Harun3, Maznah Dahlui4, Ahmad Hatim Sulaiman1,
Nor Zuraida Zainal1, Nur Aishah Taib3 and on behalf of the MyBCC Study group
Abstract
Background: Depression and anxiety are common psychiatric morbidity among breast cancer patient. There is a
lack of study examining the correlation between depression, anxiety and quality of life (QoL) with perceived social
support (PSS) among breast cancer patients. This study aims to study the level of depression, anxiety, QoL and PSS
among Malaysian breast cancer women over a period of 12 months and their associations at baseline, 6 and
12 months.
Methods: It is a 12 months prospective cohort study. Two hundred and twenty one female patients were included
in the study. They were assessed at the time of diagnosis, 6 months and 12 month using Hospital Anxiety and
Depression Scale (HADS), Quality-of-Life Questionnaire (QLQ–C30), Version 3.0 of the EORTC Study Group and
Multidimensional Scale of Perceived Social Support (MSPSS). The information of age, ethnicity, types of treatment,
and staging of cancer were collected.
Results: The HADS anxiety and depression subscales scores of the subjects were relatively low. The level of anxiety
reduced significantly at 6 and 12 months (Baseline – 6 months, p = 0.002; Baseline - 12 months, p < 0.001). There were
no changes in the level of depression over the study period. The global status of QoL and MSPSS scores were relatively
high. Correlation between the global status of QoL and MSPSS for the study subjects was positive (Spearman’s
rho = 0.31–0.36). Global status of QoL and MSPSS scores were negatively correlated with anxiety and depression.
Conclusion: Malaysian breast cancer women had relatively better QoL with lower level of anxiety and depression.
Perceived social support was an important factor for better QoL and low level of psychological distress. It reflects the
importance of attention on activities that enhance and maintain the social support system for breast cancer patients.
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Background
Breast cancer is the most common cancer diagnosed
among Malaysian females [1]. Over the decades, the sur-
vival rate among breast cancer patients improves with
early detection and advances in cancer treatment [2]. As
such, the current focus in cancer treatment is not only
about illness control but also the general wellbeing of
the patients. Quality of life (QoL) is the measure of the
patient’s perception of self-wellbeing. QoL encompasses
several aspects of functioning such as psychological,
physical, cognitive and social functioning [3]. Of the lim-
ited number of studies on QoL among breast cancer pa-
tients in Malaysia, a descriptive study involving 58
Malays and 15 Chinese women newly diagnosed with
breast cancer found that the QoL was satisfactory based
on the Malay version of the European Organization for
Research and Treatment of Cancer Quality of Life Ques-
tionnaire (EORTC QLQ-C30). There was no difference
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in the QoL between the two ethnic groups [4]. Comple-
mentary and alternative medicine (CAM) is popular
among cancer patients in Malaysia. In a cross-sectional
study on QoL among breast cancer patients under
chemotherapy, it found that the level of QoL was similar
between CAM user and non-users [5]. In general, re-
lated studies showed that the general health status scores
among breast cancer patients in Malaysia based on
EORTC QLQ-C30 was about 60 to 65, which were con-
sidered satisfactory [4, 5].
Depression and anxiety are the two most common
psychiatric comorbidities encountered in breast cancer
patients [6, 7]. Breast cancer patient may experience de-
pression and/or anxiety at any stage of their illness from
pre-diagnosis to the terminal phase of the illness. Studies
in the Western countries have shown that the prevalence
of depression ranges from 1 % to 56 %, whereas the
prevalence of depression from Asian studies is between
12.5 % and 31 % [8]. The difference in the prevalence
rate of anxiety disorders depends greatly on the type of
anxiety disorder being measured. A study by Dastan and
Buzlu [9] reported that 35 % of their breast cancer pa-
tients had anxiety, while an Asian study reported a lower
prevalence of 16 % [10]. According to Burgess et al. [11],
it seemed that the prevalence of depression and anxiety
among women with breast cancer declined from the first
year of diagnosis to the fifth year after diagnosis from
48 % to 15 %. A study of depression and anxiety among
Malaysian breast cancer patients found that the rate of
anxiety was 31.7 % and depression was 22.0 %. Younger
age, financial burden, and being single were the factors
associated with anxiety or depression among the
Malaysian breast cancer patients [12].
Social support is defined as any type of communica-
tion, in the forms of physical or psychological assistance,
for someone to feel to have more self-control during dif-
ficult times [13]. Studies showed that the positive impact
of social support does not derive from the people or in-
stitutions that form the social network. In contrast, they
may be the cause of negative impact or stress for the in-
dividual. Instead, research has shown that it is the social
support felt or perceived by the individual that produces
the positive impact [14–16]. Perceived social support is
negatively correlated with psychological distress and sui-
cidal thought in cancer patients [17]. It is also associated
with better orientation to health care services and ad-
justment to family relationship. Cancer patients with
higher level of perceived social support have a better
psychosocial adjustment to the illness [18]. Among the
different domains, support from family and friends are
shown to be associated with less breast cancer related
distress [19]. Study of the association of perceived social
support with QoL or distress among breast cancer pa-
tients in Malaysia is rare or non-existent. However, there
is indication of association between emotional/informa-
tional support and better quality of life among the eld-
erly in the rural community in Malaysia [20].
Cancer patients experience a fluctuating course of
anxiety throughout the diagnosis and treatment phases
[21, 22]. From the time of diagnosis, the cancer patients
experience different types of mental distress and adaptation
to the process of cancer treatment including investigation,
waiting for results, planning for surgery, chemotherapy,
hormonal therapy, radiotherapy and recovery [23, 24].
Interestingly, the result of a study by Kristin et al. in post-
surgery breast cancer patients showed that QoL improved
over the first 6 months. Anxiety remained unchanged after
one year but was influenced by cancer diagnosis and treat-
ment [25].
Little is known about the course of depression and
anxiety in women with breast cancer in Malaysia. There
is also no prospective study examining the changes in
QoL of breast cancer patients and its relationship with
depression, anxiety and perceived social support in
Malaysia. In the current study, we aim to study the
changes in QoL, depression and anxiety among Malay-
sian breast cancer patients from the time of diagnosis till
one year of follow up visit. We also examined the associ-
ation between the changes in QoL with depression, anx-
iety, and perceived social support in the subjects. .
Methods
This study is part of a larger study, the Malaysian Breast
Cancer Cohort (MyBCC), which is a prospective cohort
study that aims to identify the association between genet-
ics, lifestyle and nutrition on overall survival and quality
of life of Malaysian Breast Cancer patients. For further de-
tail of the cohort, please refer to the previous published
report [26]. In the current study, we mainly focused on
the natural course of anxiety depression and quality of life
among the female patients at diagnosis till 12 months of
follow up visit. The association between quality of life with
anxiety, depression, and perceived social support for the
subjects were also examined in this study.
Patients at the University of Malaya Medical Centre in
Kuala Lumpur, Malaysia, who were diagnosed with breast
cancer, were consecutively enrolled since 1 May 2011. In-
clusion criteria were: (i) breast cancer that was confirmed
by histological examination, (ii) able to complete the ne-
cessary interviews and questionnaires, and (iii) capable to
understand the objective of the study and provide in-
formed consent. Exclusion criteria were: (i) secondary
breast cancer, (ii) having confusion or delirium, and (iii)
male patients. The purpose and details of the study were
explained to all potential subjects, and participants who
gave written informed consent were enrolled. This study
was approved by the Medical Ethic Committee, University
of Malaya Medical Centre.
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Procedure and measures
All questionnaires and psychiatric measures were ad-
ministered to patients by trained clinical research coor-
dinators when patients were first diagnosed with breast
cancer (baseline). The psychiatric measures were admin-
istered again at 6 months and 12 months follow-up visits
thereafter. Information on age and ethnicity were ob-
tained. Breast cancer staging was confirmed by the treat-
ing surgeon using the American Joint Committee on
Cancer Staging System for breast cancer.
Anxiety and depression were assessed using the Malay
Version of Hospital Anxiety and Depression Scale
(HADS). HADS is the most frequently reported measure
in cancer studies and shown to be the best performing
measure for each trajectory stage of the disease. It is a
self-administered questionnaire that screens anxiety (7
items) and depressive (7 items) symptoms. It has dem-
onstrated good reliability. The anxiety (HADS-A) and
depression (HADS-D) subscales are scored from 0 to 3
(four-point Likert scales), giving maximum scores of 21
for anxiety and depression respectively [27]. The Malay
version of HADS has a good reliability and has been
validated among the Malaysian population [28].
Quality of life was measured using the Quality of Life
Questionnaire QLQ–C30, Version 3.0 of the EORTC
Study Group on Quality of Life [29]. The QLQ-C30 is
composed of both multi-item scales and single-item
measures. These include a global health status/QoL scale
and five functional scales evaluating physical function-
ing, role functioning, emotional functioning, cognitive
functioning, and social functioning. The symptom scales
and items were not included in this study. All the mea-
sures range in score from 0 to 100. Higher mean scores
on these scales represent better functioning and QoL.
The additional module QLQ–BR23 contains breast-
cancer–specific scales. Similar with previous study, we
only used three most relevant subscales: body image,
arm symptoms, and breast symptoms [25]. Higher mean
values on the arm- and breast-symptom scales indicate
an increased extent of symptoms. Higher mean scores
on the Body Image scale of the QLQ–BR23 represent
better functioning [30].
Perceived social support was measured with Multidi-
mensional Scale of Perceived Social Support (MSPSS).
MSPSS is one of the self-administered scales. It is simple
to be administered and scored. The scale consists of 12
questions and uses a 7-point Likert scale. The scoring
ranges from “strongly disagree” to “strongly agree”. The
scale has three subscales consisting of four questions to
measure namely, family, friend, and significant other
support. A high score represents high perceived social
support [31]. It was translated into the Malay language
and its psychometric properties have been established.
The Malay version of MSPSS was shown to have high
internal consistency of the total and each subscale, with
excellent factorial validity [32].
Statistical analysis
Descriptive statistics for age, ethnicity and staging of
cancer was performed. Mean and standard deviation for
all items in the QLQ-C30, HADS depression subscale
and anxiety subscale scores, MSPSS total and each do-
main subscale scores were calculated for the baseline,
6 months and at the 12 months visits. The normality of
the data was tested with Kolmogorov-Smirnov test. As
the data was non-normally distributed, the QLQ-C30,
MSPSS total and domain scores, HADS depression and
anxiety subscale scores at 6 and 12 months were com-
pared with baseline using the Wilcoxan test.
The correlation between QLQ-C30 with HADS and
MSPSS at baseline, 6 months and 12 months were exam-
ined using Spearman test. Partial correlation between
QLQ-C30 with HADS was further tested by controlling
MSPSS scores. Likewise, the partial correlation between
QLQ-C30 and MSPSS was tested by controlling the HADS
scores. All the tests were two-tailed with alpha level of 0.05.
Results
To the date of the current study in May 2015, 221 female
subjects with breast cancer were recruited in MyBCC and
had completed the 12 months follow up visit. The mean
age of the subjects is 55.1 years old (SD = 11.5) with al-
most 50 % Chinese, followed by Malays (32.1 %) and In-
dians (17.2 %). Twenty six (11.8 %) had non-invasive
breast cancer (stage 0), 60 (27.1 %) had Stage I, 83
(37.6 %) had Stage II, 44 (19.9 %) had Stage III and 8
(3.6 %) had Stage IV disease. Almost all (95.5 %) had sur-
gery with more than half had chemotherapy (59.7 %) and
radiotherapy (68.3 %). Only about one third had hormonal
therapy (Table 1).
Quality of life, perceived social support, depression and
anxiety
Quality of life of the 221 subjects was measured using
QLQ-C30 and QLQ-BR 23 at three time points; baseline,
6 months and 12 months as shown in Table 2. There is
improvement in the global health status/QoL at 12 months
as compared to baseline (Baseline – 12 months, p = 0.015)
with no significant change at 6 month (Baseline –
6 months, p > 0.05). Among the five functioning scales,
physical functioning shows significant improvement at
6 months (Baseline – 6 months, p = 0.001) and social
functioning improves at 12 months (Baseline – 12 months,
p = 0.03). There is significant improvement in emotional
functioning at both 6 and 12 months (Baseline – 6 months,
p = 0.002; Baseline - 12 months, p < 0.001). There are no
significant changes in other two functioning scales,
namely, role and cognitive.
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The mean scores of perceived social support of the
subjects are relatively high. The mean score for the total
scale is 71.50 (SD = 10.37), significant others subscale is
24.53 (SD = 3.35), family subscale is 24.90 (SD = 3.10)
and friends subscale is 22.08 (SD = 5.37). There are no
significant changes for the scores of the perceived social
support from baseline at 6 months or 12 months.
Anxiety and depression were measured with HADS and
reported at three time points. Depression is relatively low
and does not change significantly at both 6 months and
12 months’ time point (Baseline – 6 months, p = 0.932;
Baseline - 12 months, p = 0.428). There is significant
reduction in anxiety at 6 and 12 months as compared to
baseline (Baseline – 6 months, p = 0.002; Baseline -
12 months, p < 0.001) (Table 2).
Correlation between quality of life with perceived social
support, anxiety and depression
At baseline
The correlation between global health status, all function-
ing (physical, role, emotional, cognitive and social func-
tioning) and body image with anxiety or depression is
Table 1 Characteristics of the subjects (N = 221)
Characteristic












Surgery, n (%) 211 (95.5)
Chemotherapy, n (%) 132 (59.7)
Radiotherapy, n (%) 151 (68.3)
Hormonal therapy, n (%) 69 (31.2)
Table 2 Quality of life, perceived social support, anxiety and depression among the study subjects (N = 221)





Global health status/QoL 69.83 (17.23) 70.56 (16.61) 72.48 (15.68) 0.557 0.015
Functional scales
Physical functioning 91.58 (13.87) 87.77 (15.02) 72.48 (15.68) 0.001 0.236
Role functioning 93.21 (14.18) 90.11 (19.03) 91.59 (15.65) 0.066 0.280
Emotional functioning 78.17 (20.44) 83.70 (21.53) 86.89 (16.99) 0.002 0.000
Cognitive functioning 89.44 (15.70) 86.26 (18.47) 89.44 (15.70) 0.060 1.000
Social functioning 91.18 (18.64) 92.49 (15.72) 94.47 (12.98) 0.448 0.029
QLQ-BR 23
Functional scales
Body image 92.61 (16.27) 91.39 (17.39) 94.85 (13.21) 0.575 0.151
Symptoms scales
Breast symptoms 10.06 (14.39) 9.80 (14.53) 9.09 (12.92) 0.940 0.579
Arms symptoms 10.56 (18.30) 11.48 (18.09) 10.96 (16.70) 0.396 0.593
HADS
Anxiety subscale 5.42 (3.68) 4.45 (3.39) 3.75 (3.11) 0.002 0.000
Depression subscale 3.90 (3.44) 3.91 (3.31) 3.60 (3.07) 0.932 0.428
MSPSS
Significant others 24.53 (3.35) 24.10 (4.19) 23.95 (3.71) 0.510 0.104
Family 24.90 (3.10) 24.37 (3.93) 24.14 (3.34) 0.297 0.012
Friends 22.08 (5.37) 22.23 (4.91) 22.37 (4.76) 0.965 0.797
Total 71.50 (10.37) 70.70 (11.49) 70.46 (10.54) 0.666 0.404
QLQ–C30 = Quality-of-Life Questionnaire (QLQ–C30), Version 3.0 of the EORTC Study Group on Quality of Life; QLQ–BR23 Questionnaire = a breast cancer-specific
module for the QLQ; HADS = Hospital Anxiety and Depression Scale, sd = standard deviation; aWilcoxan test
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negative (r = −0.22 to −0.50). The correlations remained
significant in partial correlation analysis after controlling
for perceived social support scores. In contrast, breast and
arm symptoms based on QLQ-BR23 are positively corre-
lated with anxiety and depression. The correlation is also
significant after controlling for the perceived social sup-
port scores (Table 3).
Only global health status has statistically significant
and positive correlation with the MSPSS total and do-
main subscales scores. The correlation between func-
tioning (physical, role, emotional, cognitive and social
functioning), body image, breast and arm symptoms
with perceived social support as measured with MSPSS
after controlling for anxiety and depression are not sta-
tistically significant (Table 3).
At 6 months
The correlation between global health status, all func-
tioning (physical, role, emotional, cognitive and social
functioning) and body image with anxiety or depression
(r= −0.22 to −0.50) is negative. The correlations with de-
pression were no more significant in partial correlation ana-
lysis after controlling for perceived social support scores.
Breast symptoms based on QLQ-BR23 are positively cor-
related with anxiety and depression. The correlation with
depression was also not significant after controlling for
the perceived social support scores (Table 3).
Similar to the finding at baseline, only global health
status has statistically significant and positive correlation
with the MSPSS total and domain subscales scores. The
correlations of functioning (physical, role, emotional,
cognitive and social functioning), body image, breast and
arm symptoms with perceived social support as measured
with MSPSS are not statistically significant (Table 3).
At 12 months
Although there exist negative partial correlation between
global health status, most functioning (except role func-
tioning) and body image with anxiety or depression, the
correlations are lower as compared to baseline (pr = −0.15
to −0.38). The correlations remained significant in partial
correlation analysis after controlling for perceived social
support scores. Arm but not breast symptoms based on
QLQ-BR23 are positively correlated with anxiety and de-
pression. The correlation is also significant after control-
ling for the perceived social support scores (pr = −0.15)
(Table 3).
At baseline and 6 months, the correlation of global
health status with the MSPSS total and domain subscales
scores is positive and statistically significant. Emotional
Table 3 Correlation between anxiety, depression and perceived social support with quality of life (N = 221)
Time point: Baseline
HADS MSPSS
Anxiety subscale Depression subscale Significant other Family Friends Total
R pr1 r pr1 r pr2 r pr2 r pr2 r pr2
QLQ-C30
Global health status/QoL −0.28** −0.29** −0.22** −0.21** 0.27** 0.29 0.26** 0.24** 0.28** 0.25** 0.31** 0.30**
HADS
Anxiety subscale - - - - −0.08 - −0.074 - −0.15* - −0.12 -
Depression subscale - - - - −0.13* - −0.09 - −0.19* - −0.17* -
Time point: 6 months
QLQ-C30
Global health status/QoL -.286** −0.24** −0.32** −0.28 0.31** 0.24** 0.28** 0.21** 0.35** 0.27** 0.36** 0.27**
HADS
Anxiety subscale - - - - −0.13 - −0.11 - −0.19* - −0.16* -
Depression subscale - - - - −0.17* - −0.12 - −0.20* - −018* -
Time point: 12 months
QLQ-C30
Global health status/QoL −0.38** −0.31** −0.38** −0.27** 0.29** 0.23** 0.27** 0.17* 0.25** 0.17* 0.31** 0.22**
HADS
Anxiety subscale - - - - −0.32** - −0.35** - −0.30** - −0.35** -
Depression subscale - - - - −0.38** - −0.41** - −0.35** - −0.40** -
HADS = Hospital Anxiety and Depression Scale, MSPSS =Multidimensional Scale of Perceived Social Support, QLQ–C30 = Quality-of-Life Questionnaire (QLQ–C30),
Version 3.0 of the EORTC Study Group on Quality of Life; QLQ–BR23 Questionnaire = a breast cancer-specific module for the QLQ, r = Spearman correlation
coefficient, pr1 = partial correlation controlling for MSPSS scores, pr2 = partial correlation controlling for HADS scores; **p < 0.01; *p < 0.05
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and social functioning is positively correlated with total
MSPSS, family and significant others subscale scores
after controlling for anxiety and depression (Table 3).
Discussion
This study showed that Malaysian breast cancer patients
had relatively low levels of depression and anxiety and
high QoL at the time of diagnosis. There is no change in
the level of depression at 6 months and 1 year. In con-
trast, the level of anxiety reduced at 6 months and 1 year.
The global health status, functioning, image status, breast
and arm symptoms are all correlated with anxiety and de-
pression. The correlation with depression is insignificant
at one year. The correlation between global health status
and perceived social support is positive and statistically
significant. The level of perceived social support remained
high throughout the 12 months period of study.
Breast cancer patients are known to suffer from high
level of psychological distress at the beginning of the ill-
ness [11]. This is related to the fear and uncertainties
toward the illness and its treatment. The reported preva-
lence of distress in breast cancer patients varies depending
on the study design, settings and assessment tools. On
average, the prevalence of depression and anxiety among
cancer patients ranged from 20 to 30 % [8, 11, 33]. In the
current study, the level of depression and anxiety was
found to be comparable with previous studies. The average
scores of both HADS depression subscale and anxiety sub-
scale for the subjects in this study were lower than the
threshold score for HADS defined anxiety or depressive
disorder [27]. A striking finding was that the level of anx-
iety and depression did not change throughout the
12 months of follow up. This finding is different from the
previous study. In the study by Stafford et al., the course of
anxiety and depression of the breast cancer and gynaeco-
logical cancer patients were measured using HADS - Anx-
iety Subscale and Centre for Epidemiological Studies
Depression Scale (CES-D) at diagnosis and again every
8 weeks for 56 weeks [34]. The authors found that anxiety
and depression symptoms were highest at diagnosis with
significant improvements observed by 8 and 24 weeks, re-
spectively and maintained thereafter. The authors argued
that the depressive symptoms did not decrease signifi-
cantly at the beginning of the cancer due to the inclusion
of physical symptoms in the assessment tool like CES-D,
which they frequently encountered during the early treat-
ment stage of cancer like surgery and chemotherapy [34].
However, in the current study, we studied the depressive
symptoms using the HADS depression subscale, which
does not contain somatic symptoms in the assessment
[27]. In other words, the current finding demonstrated the
persistency of depression for 12 months after the diagnosis
in Malaysian breast cancer patients. This is in concordance
with the finding by Ferrandina et al. Their study examined
the quality of life and psychological distress among early
stage cervical cancer patients and found no changes in the
depressive symptoms after 12 months. In contrast, the
anxiety symptoms in the study by Ferrandina et al. de-
creased over time starting from 3 months after surgery
[35]. The illness and treatment related sequelae were rec-
ognized as the possible risk factor for psychological dis-
tress. For instance, lymphedema, which is a common
consequence of breast cancer, has a negative impact on pa-
tients’ body image, ability to carry on with daily activities
and social interaction.
QoL has become one of the main outcome measures
in cancer treatment [21, 22]. QoL is a multi-dimensional
measure of psychological, physical, role, cognitive and
social well-being [3]. It is shown to be closely related to
the illness progress, cancer treatment, underlying psy-
chological condition, coping strategies and social sup-
port [11, 21, 22, 25, 36]. The scores of global health
status of the study subjects were slightly higher than the
Western studies [25, 36]. In other words, the general
QoL was better in the current study group which was
comparable with the findings of other studies in Asia
[37]. We also demonstrated that the global health status
of the breast cancer subjects improved after 12 months
together with social and emotional functioning. This was
similar to the result of previous study by Kristin et al.
[25]. The improvement in QoL was expected at 6 months
to a year as most patients should have completed and
recovered from initial surgery, hospitalization, chemo-
therapy or radiotherapy [25]. At this point of time, the
patients were expected to have recovered from the initial
emotional reaction. This was reflected in the result of
the current study where emotional functioning improved
at 6 and 12 months. Another interesting finding of the
current study was the improvement of social function-
ing. This was never reported in other previous studies.
In contrast, there was report about the reduction in so-
cial, emotion and cognitive functioning, which was still
apparent at 12 months after cancer diagnosis especially
in the younger subjects. The authors argued that older
women have developed adequate strategies to cope with
disease and impairment [38].
The improvement in functioning and QoL is related to
the coping strategies. Spiritual coping is an important
coping strategy in stressful situation such as cancer.
Malaysia is a multi-ethnic country composed mainly of
Malays, Chinese and Indians. The better level of QoL
among the subjects with breast cancer could probably
reflect that Malaysian female patients turned to spiritual
coping to counter their psychological distress. Further-
more, the use of complementary and alternative medi-
cines (CAM) is common among the Malays. One local
study found that 64 % of the Malay women with breast
cancer were CAM users and they believed in the power
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of prayer and used Malay traditional medicine to assist
in healing the body’s inner strength, to cure cancer, and
to reduce stress [39]. Religious coping was also shown to
be positively correlated with lower risk of psychological
distress in other Asian studies [40]. There were qualita-
tive studies which showed that women of different cul-
tural background with breast cancer did have different
psycho-social- cultural concerns.
Many studies have shown that QoL of cancer patients
was negatively correlated with depression and anxiety
[21, 22, 41, 42]. This was also reflected in the result of
the current study. The negative relationship between
QoL with depression and anxiety was noticed at all three
time points in the current study at baseline, 6 months
and 12 months. Two previous Chinese studies reported
a correlation between anxiety and depression with
poorer quality of life in breast cancer patients under
chemotherapy or even post therapy [21, 42]. A German
study highlighted that anxiety and depression were asso-
ciated not only with the psychosocial but also the som-
atic aspects of QoL of breast cancer patients [36]. An
integrative review to explore the factors contributing to
the QoL of African American breast cancer survivor was
conducted by Mollica et al. [43]. The result showed that
psychological domains were most highly represented in
QoL domain in related studies. In a review of related lit-
erature, the findings demonstrated that depression di-
minishes quality of life, affects compliance with medical
therapies and reduces survival [22]. It argued that de-
pression impairs interpersonal relationships, occupa-
tional performance, stress and perceptions of health and
physical symptoms. Therefore, depression has a detri-
mental impact on patients’ overall quality of life.
In the current study, we demonstrated the positive
correlation between QoL and perceived social support.
The higher level of perceived social support among the
breast cancer subjects was associated with better QoL.
This finding is similar to several previous studies [17–19].
In general, the level of perceived social support measured
using MSPSS was relatively good among the subjects in
the current study in comparison with the other studies
[17, 29]. This could in another way explain the relatively
better QoL among the Malaysian breast cancer patients in
this study. The result of a Turkish study showed that per-
ceived social support is lower for family and friends espe-
cially in the advanced stage [18]. This could be due to the
higher expectation of the patients from family and friends,
physical dependency and increased discomfort. The study
also showed that low level of perceived social support is
associated with higher suicidal ideation among the cancer
patients. In another Turkish study of breast cancer patients,
the result demonstrated that social support is a detrimental
factor of adjustment to the illness [44]. Social support, par-
ticularly from the family, affects the adaptation to the illness
process. Patients seem to be more hopeful with better
social support. In another German study, social support
was also shown to be strongly associated with QoL [36].
The authors believed that social support encompasses
various aspects such as emotional which include caring
and concern, instrumental to the provision of goods and
services; and information assistance. Social support was
assumed to be the mediator or buffering of the associ-
ation between psychological distress and QoL in cancer
patients (buffering hypothesis) [45]. Not only in cancer
patient, but social support seem to be associated with
better coping among women with high risk of hereditary
breast cancer. A Dutch study showed that family com-
munication, perceived social support from family and
friends are important factors for long-term adaptation
and reduced psychological distress among women with
high risk of hereditary breast cancer [46].
In most studies, anxiety and depression were shown to
be negatively correlated with perceived social support in
cancer patients [17]. Social support buffer or mediate be-
tween psychological distress and QoL [45]. Interestingly,
our result showed that this negative relationship was not
significant in the beginning but becoming most significant
after 12 months. This is similar with other reports about
the decline in social support and increase in psychological
distress as the disease progresses [17–19, 44]. It reflects
the breakdown of contact in the respondents’ social circle
and exhaustion of social support when the disease pro-
gresses. At the same time, there is increased expectation
in social support due to physical pain and more suffering
at the later stage of cancer. Studies have shown that social
support gradually drifted away during advancement of the
disease [17]. Social support, particularly from family, is an
important factor in the adjustment to social environment,
adaptation to the disease progress and domestic environ-
ment [18, 19, 44]. As such, social support is an important
protective factor for the emotional and physical well-being
of the cancer patients.
There were several limitations in the current study.
Firstly, the study was conducted in a tertiary hospital
setting located in the capital city of the country. The
group of study subjects may not be representable to the
general population in the country. Secondly, some po-
tential associated factors of depression, anxiety and QoL
such as type of anti-cancer treatment, religiosity, under-
standing and knowledge of the illness and its treatment
were not measured in the study. Lastly, the observational
period of a year may be insufficient to demonstrate the
changes of psychological distress in breast cancer patients.
We should take into account the long term impact of the
illness and treatment on the psychological well-being of
breast cancer patients. The changes in psychological suf-
fering may require a longer period of monitoring and
assessment.
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Conclusions
In conclusion, Malaysian breast cancer patients have
relatively low levels of depression and anxiety associated
with better QoL for the first 12 months after the diagno-
sis. The higher level of QoL among breast cancer
women in Malaysia was also associated with the rela-
tively high level of perceived social support. Cancer is
becoming a major cause of morbidities and mortalities
across the globe. With the advancement in cancer treat-
ment, there is increased attention in improving the QoL
among the cancer patients. The reported level of distress
and QoL among breast cancer patients varies depending
on the coping strategies and level of acceptance in con-
cordance with local culture, belief and health care support.
The findings in the current study reflect the importance
of work in improving the caregiver system for breast can-
cer patients. Care giver support group, educational pro-
gram, and other activities that will enhance the social
support system are likely to benefit the care giver and in-
directly improve the QoL among the breast cancer pa-
tients. Prevention or reduction of psychological suffering
among the breast cancer patients such as depression and
anxiety could be achieved by improving perceived social
support.
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